Additional file 2: Supplementary Figure 2. Partial sensitive compounds.

Supplmentary figure 1

Additional file 3: Figure S3. Complementary assay. The phenotype (A) and the plant height (B) show the rescued properties in the complemented plants. Scale bars: 10 cm.

Additional file 5: Figure S5. Saccharification analysis of the wall residues from WT and cef3-c1 internodes. The wall residues were treated with enzyme mixture for 5 and 20 h. Error bars indicate SE from the mean of three replicates. Different letters denote significant differences (P < 0.05, Duncan’s multiple range test).

Additional file 5: Figure S5. Saccharification analysis of the wall residues from WT and cef3-c1 internodes. The wall residues were treated with enzyme mixture for 5 and 20 h. Error bars indicate SE from the mean of three replicates. Different letters denote significant differences (P < 0.05, Duncan’s multiple range test).

Additional file 4: Figure S4. Deduced CEF3 amino acid sequence alignments for the three homozygous mutants generated by CRISPR-Cas9 system and WT.

Additional file 1: Fig. S1. Analysis of the expression data from GEO database. The difference of the expression of H2A.Z and SFRP1 between ICC tissue and normal bile duct was visualized by box plot. (A) GSE32879. (B) GSE76297. **p<0.01, ***p<0.001.

Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) and Homeobox A5 (HOXA5) are both down-regulated in adrenocortical carcinoma (ACC), and HOXA5 is predicted to bind to the promoter of AKR1B10. We aimed to investigate whether HOXA5 could bind to AKR1B10 to regulate ACC cells proliferation and apoptosis. The expression of AKR1B10 and HOXA5 in ACC patients and the relationship of their expression between ACC prognosis were evaluated by searching database. Then, NCI-H295R cells were overexpressed to...